Biotech - MM+M - Medical Marketing and Media

Biotech

All articles by Biotech

Carisma Therapeutics appoints CFO
Carisma Therapeutics appoints CFO
Larry Dobrow
June 10, 2021
1:00 pm

Biotech veteran Richard Morris joins the company from Passage Bio.

Five things for health marketers to know: Thursday, June 3, 2021
Five things for health marketers to know: Thursday, June 3, 2021
Lecia Bushak
June 3, 2021
5:00 am

Biden administration launches community-based incentives to boost vaccinations; MorphoSys acquires Constellation Pharmaceuticals; Novartis releases promising Cosentyx results.

Five things for health marketers to know: Wednesday, June 2, 2021
Five things for health marketers to know: Wednesday, June 2, 2021
Lecia Bushak
June 2, 2021
5:00 am

FDA to decide on Biogen’s aducanumab June 7; JAMA editor Dr. Howard Bauchner steps down; Amgen pays $400 million for Kyowa Kirin’s atopic dermatitis drug.

Five things for health marketers to know: Tuesday June 1, 2021
Five things for health marketers to know: Tuesday June 1, 2021
Lecia Bushak
June 1, 2021
5:00 am

Africa will need 20 million COVID-19 doses for second shots; pandemic spurs increase in at-home care; BlueRock partners with Senti Bio on cell therapies.

Five things for health marketers to know: Thursday, May 27, 2021
Five things for health marketers to know: Thursday, May 27, 2021
Lecia Bushak
May 27, 2021
5:00 am

Researchers launch Health Equity Tracker; NiKang Therapeutics brings in $200 million in Series C funding; Large anti-vaccination efforts across U.S. aided by NY law firm.

Five things for health marketers to know: Wednesday, May 19, 2021
Five things for health marketers to know: Wednesday, May 19, 2021
Lecia Bushak
May 19, 2021
5:00 am

CDC study shows vax disparities in rural areas; oversight committee investigates AbbVie’s Humira pricing; Google launches Dermatology Assist.

Five things for health marketers to know: Tuesday, May 18, 2021
Five things for health marketers to know: Tuesday, May 18, 2021
Lecia Bushak
May 18, 2021
5:00 am

Supreme Court turns down Novartis’ Enbrel appeal; Biden administration to send 20 million vaccine doses abroad; Sanofi and GSK announce promising vaccine results in Phase II trial.

Entrada Therapeutics adds to board of directors
Entrada Therapeutics adds to board of directors
Lecia Bushak
May 11, 2021
9:00 am

Entrada Therapeutics has brought on Mary Thistle to its board of directors, where she brings 25 years of experience in finance and strategy, as well as expertise in rare diseases. She currently is special advisor at the Bill & Melinda Gates Medical Research Institute.

The MM+M Podcast 9.9.2020: Alexion Pharmaceuticals’ Tamar Thompson
The MM+M Podcast 9.9.2020: Alexion Pharmaceuticals’ Tamar Thompson
MM+M Staff
September 9, 2020
5:00 am

Tamar Thompson, VP of government affairs and policy at Alexion Pharmaceuticals, speaks about how the biotech company has evolved on the D&I front.

We’ve got your 2019 pharma marketing milestones right here
We’ve got your 2019 pharma marketing milestones right here
Marc Iskowitz
December 19, 2019
5:00 am

Marketers and consultants across biopharma, med-tech and agency recall the marketing milestones that defined the past year.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners